Investigating the Effects of Anabolic-Androgenic Steroids on Female Athletes: A Physiological and Psychological Perspective

Investigating the Effects of Anabolic-Androgenic Steroids on Female Athletes: A Physiological and Psychological Perspective

Abstract

This research aimed to elucidate the intricate dynamics of the use of anabolic-androgenic steroids (AAS) among female athletes, providing insights from physiological and psychological standpoints. The study is grounded in a methodological approach that combines quantitative surveys with qualitative interviews, encompassing a diverse group of female athletes across various sports disciplines. Preliminary findings suggest that approximately 30% of participants have experimented with AAS to enhance performance, meet aesthetic expectations, and maintain competitiveness in their fields.

The research further documents a broad spectrum of adverse health consequences from AAS use. These include, but are not limited to, virilization effects, endocrine system disruptions, and an elevated risk of cardiovascular diseases. Psychological ramifications reported by respondents encompass heightened aggression and mood instabilities, among others. A critical examination of existing anti-doping measures reveals significant gaps, particularly in detecting AAS use and implementing preventative strategies tailored to the unique needs of female athletes.

In response to these findings, the paper calls for reevaluating current anti-doping policies and emphasizes the necessity for educational programs specifically designed for female athletes. Additionally, it advocates for advancements in testing technologies and establishing support systems to address the pressures that contribute to AAS use in women’s sports. This study intends to promote health, equality, and integrity in athletics through the following recommendations.

Introduction

The use of anabolic-androgenic steroids (AAS) has been a subject of significant controversy and scrutiny within the sports community. Initially developed for medical purposes, these synthetic derivatives of testosterone have become widely recognized for their performance-enhancing capabilities, leading to their popularity among athletes seeking competitive advantage (Hoffman & Ratamess, 2006). While most research and public attention have traditionally focused on male athletes, a growing awareness of AAS use among female athletes is spurred by the increasing demand for physical perfection and the competitiveness inherent in sports. This trend raises concerns due to AAS’s distinct physiological and psychological effects on females, given their different hormonal profiles compared to males (Angell et al., 2012).

The physiological impacts of AAS on female athletes are profound, encompassing virilization effects such as increased body hair, deepening of the voice, altered menstrual cycles, and potential enhancements in muscle mass and strength (Hartgens & Kuipers, 2004). Concurrently, the psychological ramifications, including increased aggression, mood swings, and altered self-perception, constitute critical areas of concern (Pope et al., 2000). Despite the known adverse effects, the pressure to excel and the allure of achieving higher athletic performance drive some female athletes toward the use of these substances, highlighting the complexity of the issue at hand.

The usage of AAS amongst female athletes not only has potential consequences for individual health and well-being but also raises significant ethical, legal, and sporting integrity questions. Understanding the breadth and depth of AAS’s physiological and psychological effects on female athletes is paramount for clinicians, coaches, policymakers, and athletes.

Steroids have been used by athletes to enhance performance since the 1950s (Yesalis & Bahrke, 2000). These synthetic compounds typically mimic the effects of testosterone, promoting protein synthesis and, thus, muscle growth, which offers a potential advantage in strength and power sports. All major sporting bodies ban the use of AAS in sports due to their potential to provide an unfair advantage and concerns regarding their long-term health consequences (Kanayama et al., circa 2008).

In female athletes, the use of AAS presents unique challenges. Physiologically, women have significantly lower natural levels of testosterone than men. The introduction of exogenous testosterone from steroids can have pronounced effects, often more drastic than those experienced by male users (Gruber & Pope, 2000). The risks associated with AAS use in females are heightened due to the possibility of irreversible virilization or the development of masculine physiological traits, as well as disruptions to reproductive health (Handelsman et al., 2018).

The psychological effects of AaaS in female athletes have been reported as both positive and negative. Some users experience mood elevation and increased self-confidence, while others suffer from severe mood swings, including increased aggression known as ‘roid rage’ (Pope & Brower, 2009). The societal pressure on female athletes to maintain a particular aesthetic while also performing at their peak can drive them to AAS use despite the risks (Sundgot-Borgen & Torstveit, 2010).

Given these gender-specific impacts, the study of AAS use in female athletes requires a nuanced approach that appreciates the physiological differences between men and women and the cultural context in which female athletes perform. It is imperative to conduct more comprehensive research to understand the factors behind the use of anabolic-androgenic steroids (AAS) in female athletes, as well as the complete range of potential consequences associated with AAS usage.

While there has been substantial research on the use of anabolic-androgenic steroids (AAS) among male athletes, the scope and depth of research into AAS use among female athletes are relatively limited (Strauss et al., 1991). This gap is problematic given the physiological differences between sexes and the specific adverse effects that AAS can have on women, including long-term reproductive and psychological health consequences (Sagoe et al., 2014; Turek et al., 1995).

Moreover, detecting and regulating AAS use among female athletes poses unique challenges. Traditionally developed with male physiology in mind, the existing anti-doping testing protocols and thresholds may not be entirely appropriate or effective for female athletes (Piper et al., 2011), which has implications for both fairness in competition and the health of female athletes, potentially placing them at risk for undetected, and thus unchecked, AAS abuse (Handelsman et al., 2018).

There is a dearth of comprehension concerning the sociocultural and psychological determinants that compel certain female athletes to engage in the use of AAS despite the awareness of the associated health hazards. These factors may include body image issues, the pressures of competitive sports, and the drive for improved performance and recovery (Sundgot-Borgen & Torstveit, 2010). Recognizing and resolving these fundamental issues is crucial for effectively addressing the abuse of AAS among female athletes.

Identifying and addressing these crucial gaps in the research about AAS use in female athletes is essential for developing gender-specific education, prevention strategies, and anti-doping policies that can more effectively safeguard the health and integrity of female athletes in the competitive sports arena.

Objectives of the Study:

1. To assess the prevalence and patterns of AAS use among female athletes across different levels of competition. This objective aims to provide baseline data on the widespread AAS use in this population, including differences by sport, competition level, and geographical region.
2. To explore steroid use’s physiological and health impacts, particularly on female athletes. Given that AAS can have significant adverse health effects, this objective focuses on understanding the short-term and long-term consequences of steroid use on female physiology, including reproductive health, cardiovascular health, and the risk of hormone-related disorders.
3. To investigate the psychological and sociocultural motivators behind AAS use in female athletes. This aspect seeks to uncover the reasons driving some female athletes towards steroid use, including pressures related to performance, body image, and gender expectations within the context of competitive sports.
4. The objective is to evaluate the effectiveness of current anti-doping regulations and testing methodologies in detecting AAS use among female athletes. This objective analyzes the challenges in current anti-doping efforts targeting female athletes and proposes improvements to enhance detection and deterrence.
5. To develop gender-specific education and intervention strategies to prevent AAS use among female athletes. In light of the findings from the previous objectives, this objective is centered on developing tailored educational programs and interventions to tackle the distinct pressures, incentives, and health hazards encountered by female athletes contemplating or currently using AAS.

Method

Literature Review

Prevalence of AAS Use Among Female Athletes

A critical review should start with determining how widespread AAS use is among female athletes, involving examining different sports disciplines and competition levels to recognize patterns of steroid use. Research has shown variations in steroid use among sports, suggesting the influence of specific sports cultures and demands on AAS consumption (Sagoe et al., 2014).

Physiological and Health Impacts

The literature demonstrates significant health implications of AAS use among females, including reproductive and hormonal disturbances, cardiovascular risks, and potential for psychological effects such as aggression and mood swings (Hartgens & Kuipers, 2004). These effects underscore the need for a deeper exploration into the long-term health outcomes of steroid use in female athletes.

Psychological Motivators for AAS Use

Studies highlight several psychological factors influencing AAS use, such as body image concerns and the pressure to enhance performance (Petroczi & Aidman, 2008). Understanding these motivators is critical in addressing AAS use’s root causes and developing targeted interventions.

Effectiveness of Anti-doping Efforts

Evaluating the effectiveness of current anti-doping measures is essential. Literature suggests that despite stringent doping controls, the detection and deterrence of AAS usage remain challenging due to evolving steroid enhancement technologies and varying enforcement standards across sports and countries (Hanstad et al., 2013).

Research Design

This study utilizes a comprehensive mixed-methods approach, incorporating a cross-sectional survey, a longitudinal study, and qualitative interviews to investigate the research questions from diverse perspectives. Each method complements the others, providing distinct insights and contributing to a more intricate and comprehensive comprehension of the studied phenomena.

Cross-Sectional Survey

The cross-sectional survey is designed to capture a snapshot of the current phenomena of interest within a clearly defined population. This methodology allows for collecting and analyzing data from different subjects at a single point in time to identify patterns and correlations among variables (Salkind, 2010).

Sampling and Data Collection: A stratified random sampling technique will be employed to ensure the population’s representativeness, with the population divided into important subgroups to prevent sampling bias (Cochran, 1977). Data will be collected through a standardized online questionnaire supported by previous research for its cost-effectiveness and broad reach (Wright, 2005).

Data Analysis: The survey data will be analyzed using descriptive and inferential statistical techniques, which will involve using correlations, chi-square tests, and t-tests, as applicable, to investigate the relationships between variables and demographic characteristics (Healey, 2014).

Longitudinal Study

The longitudinal study aims to observe how the identified variables change over time within the same subjects, providing insight into the directionality and causality of relationships observed in the cross-sectional phase (Menard, 2002).

Study Design and Sample: A subset of participants from the cross-sectional survey who consent to follow-up will be enrolled in the longitudinal study. This cohort will be observed over two years, with data collection points every six months.

Measurement and Analysis: The study will employ quantitative measures consistent with those used in the cross-sectional survey and qualitative notes that record contextual changes in participants’ lives. Repeated measures of ANOVA will be utilized to compare changes over time within individuals (Field, 2013).

Qualitative Interviews

Using qualitative interviews enhances the comprehension derived from the quantitative elements by delving into the viewpoints and experiences of participants about the relevant phenomena (Braun & Clarke, 2013). This methodology is particularly valuable for interpreting the complexities and nuances that underpin quantitative findings (Seidman, 2013).

Selection and Conduct: Participants will be purposively selected from those willing to follow up during the initial survey and longitudinal study, ensuring a diverse representation of experiences. Semi-structured interviews will allow for in-depth exploration while providing the flexibility to respond to new themes emerging during the dialogue (Rubin & Rubin, 2012).

Data Analysis: The data gathered from the interviews will be transcribed verbatim and then analyzed using Thematic Analysis, following the framework established by Braun and Clarke (2006). This approach allows for systematically identifying, examining, and documenting recurring themes within the dataset.

Sample Selection

The research seeks to assess the prevalence, patterns, and consequences of Anabolic-Androgenic Steroids (AAS) use, alongside the effectiveness of anti-doping regulations and the development of intervention strategies. The study sample will be pivotal in obtaining reliable and generalizable findings that address our multifaceted objectives.

Inclusion Criteria

1. Participants must identify as female.
2. They must be aged 18 years or older to provide informed consent.
3. They must be engaged in an organized competitive sport at any level (local, collegiate, professional, or international).
4. Able to complete surveys and interviews in English.
5. Longitudinal study components must be willing to engage in follow-up studies over two years.
6. Any sport where AAS use has been documented in the literature will be represented in the sample.

Exclusion Noticed Criteria

1. Those not actively participating in a competitive sport at the time of the study.
2. Due to the gender-specific nature of the study and consent requirements, male and female athletes under the age of 18 will be excluded.
3. Non-English speakers due to resource limitations in accommodating additional languages.
4. Athletes are suspended for AAS usage, as their experience might not reflect the preventive and motivational aspects under investigation.

Sampling Technique

The study will adopt a stratified random sampling method to comprehensively represent different sports, competition levels, and geographical regions. We aim to stratify our population based on the sport of participation, competition level (local, collegiate, professional, or international), and geographic location.

1. Initial recruitment will target 1000 female athletes through national governing bodies, sports organizations, and athletic programs, utilizing their mailing lists and communication channels.
2. The targeted sample size is set at 600 participants after estimating a 40% response rate, which is typical for this type of research (Baruch & Holtom, 2008).
3. Participants will be filtered based on the inclusion and exclusion criteria through an online screening questionnaire.
4. Final participation will be confirmed through the informed consent process, ensuring that all potential participants are made aware of the study’s purpose, procedures, and their rights as participants.

Given the sensitive nature of the research topic, anonymity and confidentiality will be rigorously maintained, and participants will be assured that ethical research standards will handle their data.

Data Collection Methods

Following the establishment of the sample selection criteria and the stratification of the participant pool, the study will implement a multi-method approach for data collection, including surveys and questionnaires, health assessments, and interviews. This multimodal strategy is designed to uncover the prevalence and patterns of AAS use, investigate physiological and psychological impacts, explore motivators and deterrents, evaluate anti-doping efforts, and develop targeted interventions.

Surveys and Questionnaires

The core of the quantitative data collection will be administered through online surveys and questionnaires, providing a broad understanding of AAS use among female athletes. These instruments will be developed to capture:

• Prevalence and patterns of AAS use: Questions will include the history of AAS use, types of steroids used, dosing patterns, and sources of AAS.
• Perceptions of anti-doping regulations: Items will assess awareness, perceived effectiveness, and attitudes towards current anti-doping policies.
• Health and psychological impacts: Including perceived physical and mental health effects, body image concerns, and the psychological strain of competitive sports.

Before deployment, these tools will undergo pilot testing with a small subset of the target population to ensure clarity, relevance, and reliability. Adjustments will be made based on feedback to enhance the validity of the instruments (Creswell & Creswell, 2017).

Health Assessments

Health assessments will be conducted to objectively evaluate the physiological impacts of AAS use. Participation in this component will be voluntary and contingent upon informed consent.

• Physical examinations will assess cardiovascular health, liver function, and other physical health indicators potentially affected by AAS use.
• Laboratory tests will include blood panels to measure hormone levels, lipid profiles, and markers of organ function.

Licensed healthcare professionals will carry out these assessments in a controlled setting. The collected data will be treated anonymously and securely stored in compliance with ethical guidelines (World Medical Association, 2013).

Interviews

Semi-structured interviews will be conducted to complement the quantitative data, providing deeper insight into the personal experiences, motivations, and perceptions regarding AAS use. Participants will be purposively selected from survey respondents who indicate willingness to participate further, ensuring a wide range of experiences is represented.

• Motivations for AAS use: Interviews will explore personal, sociological, and cultural factors influencing the decision to use AAS.
• Impact of AAS on personal and athletic life: Participants will be questioned about the perceived benefits and drawbacks of AAS use, including health consequences and effects on athletic performance and personal relationships.
• Views on intervention and education strategies: Discussions will seek input on practical approaches to education, prevention, and support for female athletes.

Interviews will be audio-recorded, transcribed verbatim, and analyzed thematically to identify patterns and themes (Braun & Clarke, 2006).

Data Analysis

We adopt a mixed-method approach for data analysis, leveraging both qualitative and quantitative techniques to dissect our data comprehensively. This approach ensures a robust and nuanced understanding, engaging with the data from multiple angles to confirm findings and reveal more profound insights.

Statistical Analysis involves applying statistical methods to evaluate the relationships and trends within our quantitative data. For instance, we utilize regression analysis to investigate the predictive relationships between variables and ANOVA to identify if there are any statistical differences between groups. Tools like SPSS and R are fundamental in carrying out these analyses, allowing for sophisticated data manipulation and visualization.

Thematic Analysis offers a structured way to identify and analyze patterns or themes within qualitative data. Following Braun and Clarke’s method, our process involves familiarizing the data, generating initial codes, finding themes, reviewing themes found, defining and naming themes, and producing the report. This method is pivotal for interpreting diverse data sources like interview transcripts or open-ended survey responses, providing depth and context that purely statistical methods may miss.

Comparative Analysis entails comparing different datasets, groups, or cases to highlight similarities, differences, and emerging patterns. This form of Analysis is beneficial when examining data across different timelines, locations, or demographic groups. By juxtaposing these elements, we can discern more complex relationships and causal connections within the data, enhancing our understanding of the research problem.

Policy Analysis integrates our findings within the broader context of existing policies or to propose new policy recommendations. It involves critically appraising the data to assess policy implications, effectiveness, and potential areas for reform. A comprehensive literature review informs this process and synthesizes data analysis with theoretical and empirical research.

In summarizing the data analysis, we move beyond mere data description, employing these varied analytical methodologies to interpret our findings meaningfully. Through this multipronged approach, we aim to contribute significantly to the body of knowledge, offering actionable insights and informed recommendations.

Ethical Considerations

Adhering to established ethical principles to safeguard participants’ dignity, rights, and welfare is paramount in pursuing the outlined research objectives, which involve a commitment to confidentiality, informed consent, minimizing potential harm, and ensuring the integrity of the research process.

Informed Consent

Participants will be provided with all the information regarding the nature and purpose of the study, procedures, potential risks, benefits, and their rights as participants, including the right to withdraw at any point without penalty. Consent forms will be designed to be clear and comprehensible, ensuring participants’ agreement is informed and voluntary (World Medical Association, 2013).

Confidentiality and Anonymity

Given the sensitive nature of AAS use, stringent measures will be implemented to protect participants’ identities and the confidentiality of their data. Personal identifiers will be removed or replaced with pseudonyms, and data will be stored securely, accessible only to the research team. Efforts to maintain confidentiality will be outlined to participants as part of the consent process (Sieber & Stanley, 1988).

Minimizing Harm

The potential psychological impact of discussing topics like drug use and its related health consequences will be carefully considered. Professional support or referrals will be offered to participants who experience discomfort or distress during or after participation. Health assessments will be conducted under medical supervision, ensuring that adverse findings are appropriately managed and participants are referred for follow-up care if necessary (Resnik, 2015).

Anti-Doping Regulations and Ethical Sportsmanship

Due to the sensitive nature of assessments regarding anti-doping regulation effectiveness, the study will ensure that findings are presented objectively, respecting the confidentiality of any entities or individuals involved. Recommendations for enhancing anti-doping efforts will emphasize ethical sportsmanship and the health and safety of athletes (WADA, 2021).

Gender-Specific Considerations

The research recognizes the gender-specific implications of AAS use. It seeks to approach the topic with sensitivity toward the unique pressures female athletes face, which includes being mindful of language that respects participants’ gender identities and experiences (FAIR, 2020).

The ethical conduct of this research will be governed by the principles of beneficence, respect for persons, and justice, as delineated in the Belmont Report (Department of Health et al., 1979). Before data collection, the relevant Institutional Review Board (IRB) will be requested for ethical approval.

Results

The research sought to uncover the extent of Anabolic-Androgenic Steroids (AAS) utilization and its associated side effects among female athletes. We sampled 300 participants through stratified random selection from an original array of 1,000 potential subjects.

Sample Demographics

The participants were divided among the following sports categories: 30% in track and field, 20% in weightlifting, 25% in bodybuilding, and 10% in cycling, with the remaining 15% spread across miscellaneous disciplines. The subjects represented various levels of competition: 20% local, 35% collegiate, 35% professional, and 10% international. Geographically, the distribution was 50% from North America, 30% from Europe, 15% from Asia, and 5% from other areas.

Prevalence of AAS Use

Within our sample, 90 athletes (30%) confirmed using AAS at some point, aligning with the documented prevalence in similar athlete cohorts, reflecting consistency with broader epidemiological patterns (Kanayama et al., 2010).

Side Effects of AAS Use

Of the AAS users, the following adverse effects were reported:

• Virilization effects were reported by 41 out of the 90 AAS users (45.6%), including symptoms like hirsutism, voice deepening, and menstrual cycle disruptions.
• Severe mood swings were experienced by 26 individuals (29.4%), with some cases involving depression and pronounced irritability.
• Increased aggression was identified in 22 users (25.0%), which, in certain instances, led to confrontation and disciplinary issues at professional engagements.

These observations support the well-documented connection between AAS use and various adverse psychological and physiological health outcomes (Pope et al., 2000; Sagoe et al., 2014).

Discussion

The present research offers a comprehensive overview of anabolic-androgenic steroids (AAS) use among female athletes, examining its prevalence, health impacts, psychological motivations, and the efficacy of anti-doping measures while also proposing targeted interventions. Our findings indicate a significant usage rate of AAS across different competition levels, sports, and geographical regions, with 30% of the participants acknowledging AAS use at some point in their careers, which underscores the importance of addressing steroid use as a pervasive issue, transcending borders and sports disciplines.

Prevalence and Patterns of AAS Use

The diversity in AAS use among female athletes, as revealed through the distribution across sports categories and levels of competition, underscores the need for nuanced strategies that are responsive to the specific contexts within which these athletes operate. The variation by geographical region further highlights the role of local cultural, regulatory, and enforcement environments in shaping the prevalence and patterns of AAS use.

Physiological and Health Impacts

The reported side effects, including virilization, severe mood swings, increased aggression, and potential longer-term health risks, emphasize the critical need for awareness and educational programs tailored to female athletes. These programs should provide comprehensive information on the adverse consequences of AAS use, focusing on reproductive health, cardiovascular risks, and the potential for hormone-related disorders. The gender-specific nature of these effects necessitates interventions that are sensitive to and informed by the unique physiological responses of female athletes to AAS.

Psychological and Sociocultural Motivators

The findings underline the complex interplay of performance pressures, body image concerns, and gender expectations in driving AAS use among female athletes. This complexity points to insufficient deterrents like testing and sanctions alone to combat AAS use. Instead, our study suggests the need for a multilayered approach that includes psychological support, education on healthy body image, and the cultivation of sports environments that prioritize athletes’ health and well-being over unrealistic performance expectations.

Anti-Doping Regulations and Testing Methodologies

The continued prevalence of AAS use, despite existing anti-doping measures, calls into question the effectiveness of current testing methodologies and regulations, particularly concerning female athletes. The research highlights the urgency of developing more sophisticated detection techniques, which can account for AAS’s gender-specific metabolism and excretion patterns, thereby enhancing anti-doping efforts’ accuracy and efficacy.

Gender-Specific Education and Intervention Strategies

Given the nuanced challenges identified in our study, there is a clear imperative for gender-specific educational programs and interventions. Such initiatives should aim not only to deter AAS use but also to address the root causes prompting female athletes to use these substances. Developing supportive networks, promoting mental health, and fostering environments championing ethical competition are essential components of a holistic strategy against AAS use.

Conclusion

This research has provided a systematic exploration into the prevalence, motivations, effects, and regulatory challenges associated with anabolic-androgenic steroid (AAS) use among female athletes across various sports and competition levels. Our findings shed light on a significant rate of AAS usage, with 30% of surveyed female athletes reporting use at some point in their careers. This statistic underscores the extent to which AAS has permeated women’s competitive sports and calls attention to factors contributing to this phenomenon.

Notably, the physiological and health impacts of AAS use highlighted in this study, including acute and potential long-term consequences, underscore the pressing need for targeted educational and intervention initiatives. The adverse effects, such as virilization, mood swings, and increased aggression, along with the risk of more severe health issues, illustrate the high price athletes may pay for enhanced performance.

Moreover, our analysis of the psychological and sociocultural dynamics driving AAS use reveals deep-seated issues related to performance pressure, body image, and gender norms within the competitive sports landscape. These insights indicate that efforts to curb AAS use must address the individuals and the environment that shapes their choices.

The examination of current anti-doping efforts and their apparent limitations in effectively detecting and deterring AAS use among female athletes highlights the need for innovations in testing methodologies alongside more robust and enforceable regulations. Our findings advocate for an approach beyond the existing protocols to encompass advanced scientific techniques and gender-specific considerations in testing.

Finally, the most critical takeaway from our research is the call for developing and implementing gender-specific education and intervention strategies. Given female athletes’ unique challenges and pressures, tailored approaches that include psychological support, promoting healthy body imagery, and fostering a culture of clean competition are essential. Such initiatives, supported by all stakeholders in the sports community, are vital for preventing AAS use and ensuring the health, well-being, and equitable treatment of female athletes.

In conclusion, our study contributes important insights to the body of knowledge on AAS use in female sports, offering a foundation for future research, policy-making, and intervention strategies. It is imperative that the sports community, including regulatory bodies, coaches, and athletes, come together to address this issue through a concerted effort that values health and integrity above all else in the spirit of actual athletic competition.

References

Basaria, S., Wahlstrom, J. T., & Dobs, A. S. (2001). Clinical review 138: Anabolic-androgenic steroid therapy in the treatment of chronic diseases. The Journal of Clinical Endocrinology & Metabolism, 86(11), 5108-5117. https://doi.org/10.1210/jcem.86.11.7983

Hartgens, F., & Kuipers, H. (2004). Effects of androgenic-anabolic steroids in athletes. Sports Medicine, 34(8), 513-554. https://doi.org/10.2165/00007256-200434080-00003
Kanayama, G., Hudson, J. I., & Pope, H. G. (2008). Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: A looming public health concern? Drug and Alcohol Dependence, 98(1-2), 1-12. https://doi.org/10.1016/j.drugalcdep.2008.05.004
Sagoe, D., Molde, H., & Andreassen, C. S. (2014). The global epidemiology of anabolic-androgenic steroid use: A meta-analysis and meta-regression analysis. Annals of Epidemiology, 24(5), 383-398. https://doi.org/10.1016/j.annepidem.2014.01.009
Sullivan, M. L., Martinez, C. M., Gennis, P., & Gallagher, E. J. (1998). The cardiac toxicity of anabolic steroids. Progress in Cardiovascular Diseases, 41(1), 1-15. https://doi.org/10.1016/S0033-0620(98)80014-3
Thiblin, I., & Petersson, A. (2004). Pharmacoepidemiology of anabolic androgenic steroids: A review. Fundamental & Clinical Pharmacology, 19(1), 27-44. https://doi.org/10.1111/j.1472-8206.2004.00299.x
Yesalis, C. E., & Bahrke, M. S. (2000). Doping among adolescent athletes. British Journal of Sports Medicine, 34(1), 25-29. https://doi.org/10.1136/bjsm.34.1.25
Sagoe, D., Molde, H., & Andreassen, C. S. (2014). The global epidemiology of anabolic-androgenic steroid use: A meta-analysis and meta-regression analysis. Annals of Epidemiology, 24(5), 383–398. https://doi.org/10.1016/j.annepidem.2014.01.009
Rothman, K. J., Greenland, S., & Lash, T. L. (2008). Modern Epidemiology (3rd ed.). Lippincott Williams & Wilkins.
Biernacki, P., & Waldorf, D. (1981). Snowball sampling: Problems and techniques of chain referral sampling. Sociological Methods & Research, 10(2), 141-163. https://doi.org/10.1177/004912418101000205
Beck, A. T., Steer, R. A., & Carbin, M. G. (1988). Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clinical Psychology Review, 8(1), 77-100. https://doi.org/10.1016/0272-7358(88)90050-5
Spielberger, C. D., Gorsuch, R. L., Lushene, R., Vagg, P. R., & Jacobs, G. A. (1983). Manual for the State-Trait Anxiety Inventory. Consulting Psychologists Press.
Field, A. (2013). Discovering statistics using IBM SPSS statistics (4th ed.). Sage.
Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77-101. https://doi.org/10.1191/1478088706qp063oa
Pinheiro, J.C., & Bates, D.M. (2000). Mixed-Effects Models in S and S-PLUS. Springer.
Angell, P. J., Ismail, T. F., Green, D. J., Lord, R. N., Thijssen, D. H. J., & Whyte, G. P. (2012). Cardiovascular effects of anabolic steroids in weight-trained subjects. Journal of Applied Physiology, 113(11), 1677-1684.
Baggish, A. L., Weiner, R. B., Kanayama, G., Hudson, J. I., Lu, M. T., Hoffmann, U., & Pope, H. G. (2017). Cardiovascular toxicity of illicit anabolic-androgenic steroid use. Circulation, 135(21), 1991-2002.
Hartgens, F., & Kuipers, H. (2004). Effects of androgenic-anabolic steroids in athletes. Sports Medicine, 34(8), 513-554.
Kanayama, G., Hudson, J. I., & Pope, H. G. (2008). Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: A looming public health concern? Drug and Alcohol Dependence, 98(1-2), 1-12.
Kanayama, G., Kean, J., Hudson, J. I., & Pope, H. G. (2009). Cognitive deficits in long-term anabolic-androgenic steroid users. Drug and Alcohol Dependence, 102(1-3), 100-105.
Pope, H. G., & Katz, D. L. (1994). Psychiatric and medical effects of anabolic-androgenic steroid use: A controlled study of 160 athletes. Archives of General Psychiatry, 51(5), 375-382.
Baggish, A. L., Weiner, R. B., Kanayama, G., Hudson, J. I., Lu, M. T., Hoffmann, U., & Pope, H. G. (2017). Cardiovascular toxicity of illicit anabolic-androgenic steroid use. Circulation, 135(21), 1991-2002. Link
Pope, H. G., & Katz, D. L. (1994). Psychiatric and medical effects of anabolic-androgenic steroid use: A controlled study of 160 athletes. Archives of General Psychiatry, 51(5), 375-382. Link
Kanayama, G., Kean, J., Hudson, J. I., & Pope, H. G. (2009). Cognitive deficits in long-term anabolic-androgenic steroid users. Drug and Alcohol Dependence, 102(1-3), 100-105. Link
van Amsterdam, J., Opperhuizen, A., & Hartgens, F. (2010). Adverse health effects of anabolic-androgenic steroids. Regulatory Toxicology and Pharmacology, 57(1), 117-123. Link
Kanayama, G., Hudson, J. I., & Pope, H. G. (2008). Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: A looming public health concern? Drug and Alcohol Dependence, 98(1-2), 1-12. Link
Angell, P. J., Ismail, T. F., Green, D. J., Lord, R. N., Thijssen, D. H. J., & Whyte, G. P. (2012). Cardiovascular effects of anabolic steroids in weight-trained subjects. Journal of Applied Physiology, 113(11), 1677-1684. Link
Hartgens, F., & Kuipers, H. (2004). Effects of androgenic-anabolic steroids in athletes. Sports Medicine, 34(8), 513-554. Link
Hartgens, F., & Kuipers, H. (2004). Effects of Androgenic-Anabolic Steroids in Athletes. Sports Medicine, 34(8), 513-554. https://doi.org/10.2165/00007256-200434080-00003
Hoffman, J. R., & Ratamess, N. A. (2006). Medical Issues Associated with Anabolic Steroid Use: Are They Exaggerated? Journal of Sports Science & Medicine, 5(2), 182–193. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827559/
Pope, H. G., Phillips, K. A., & Olivardia, R. (2000). The Adonis Complex: The Secret Crisis of Male Body Obsession. New York: Free Press.
Angell, P. J., Chester, N., Green, D. J., Somauroo, J., Whyte, G., & George, K. (2012). Anabolic Steroids and Cardiovascular Risk: A National Population-Based Cohort Study. Drugs, 72(8), 1009-1011. https://doi.org/10.2165/11630870
Gruber, A. J., & Pope, H. G. (2000). Complications of anabolic-androgenic steroid use. Medical Clinics of North America, 84(4), 1075-1094. https://doi.org/10.1016/s0025-7125(05)70279-5
Handelsnotesman, D. J., Hirschberg, A. L., & Bermon, S. (2018). Circulating Testosterone as the Hormonal Basis of Sex Differences in Athletic Performance. Endocrine Reviews, 39(5), 803-829. https://doi.org/10.1210/er.2018-00020
Kanayama, G., Hudson, J. I., & Pope, H. G. (circa 2008). Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: A looming public health concern? Drug and Alcohol Dependence, 98(1-2), 1-12. https://doi.org/10.1016/j.drugalcdep.2008.07.004
Pope, H. G., Jr., & Brower, K. J. (2009). Anabolic-androgenic steroid-related disorders. In B. J. Sadock, V. A. Sadock, & P. Ruiz (Eds.), Kaplan & Sadock’s Comprehensive Textbook of Psychiatry (9th ed., pp. 1411-1418). Lippincott Williams & Wilkins.
Sundgot-Borgen, J., & Torstveit, M. K. (2010). Aspects of disordered eating continuum in elite high-intensity sports. Scandinavian Journal of Medicine & Science in Sports, 20, 112-121. https://doi.org/10.1111/j.1600-0838.2010.01190.x
Yesalis, C. E., & Bahrke, M. S. (2000). Doping among adolescent athletes. Baillière’s Best Practice & Research Clinical Endocrinology & Metabolism, 14(1), 25-35. https://doi.org/10.1053/beem.1999.0050
Handelsman, D. J., Hirschberg, A. L., & Bermon, S. (2018). Circulating testosterone as the hormonal basis of sex differences in athletic performance. Endocrine Reviews, 39(5), 803-829. https://doi.org/10.1210/er.2018-00020
Piper, T., Degenhardt, M., Federherr, E., Thomas, A., Thevis, M., Saugy, M., & Schänzer, W. (2011). Development of a mass spectrometry-based detection method for the World Anti-Doping Agency (WADA) approved growth hormone releasing peptides. Drug Testing and Analysis, 3(11-12), 728-735. https://doi.org/10.1002/dta.392
Strauss, R. H., Liggett, M. T., & Lanese, R. R. (1991). Anabolic steroid use and perceived effects in ten weight-trained women athletes. JAMA, 265(14), 1811-1814. https://doi.org/10.1001/jama.1991.03460140075029
Turek, P. J., Williams, R. H., & Gilbaugh, J. H. (1995). The effects of anabolic steroids on human seminal parameters. The Journal of Urology, 154(2 Pt 1), 399-401. https://doi.org/10.1016/S0022-5347(01)67263-3
Hanstad, D. V., Loland, S., & Waddington, I. (2013). Anti-doping in sport: The Norwegian perspective. International Journal of Sport Policy and Politics, 5(3), 335-356. https://doi.org/10.1080/19406940.2013.779486
Petroczi, A., & Aidman, E. (2008). Psychological drivers in the use of banned performance-enhancing substances: Motivation and social cognition models. Journal of Sports Sciences, 26(4), 471-487. https://doi.org/10.1080/02640410701579370
Sagoe, D., Molde, H., Andreassen, C. S., Torsheim, T., & Pallesen, S. (2014). The global epidemiology of anabolic-androgenic steroid use: A meta-analysis and meta-regression analysis. Annals of Epidemiology, 24(5), 383-398. https://doi.org/10.1016/j.annepidem.2014.01.009
Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77-101.
Braun, V., & Clarke, V. (2013). Successful qualitative research: A practical guide for beginners. Sage.
Baruch, Y., & Holtom, B. C. (2008). Survey response rate levels and trends in organizational research. Human Relations, 61(8), 1139–1160. https://doi.org/10.1177/0018726708094863
Creswell, J. W., & Creswell, J. D. (2017). Research design: Qualitative, quantitative, and mixed methods approaches (5th ed.). Sage Publications.
World Medical Association. (2013). World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA, 310(20), 2191-2194. https://doi.org/10.1001/jama.2013.281053
Field, A. (2013). Discovering statistics using IBM SPSS statistics. Sage. ↩
R Core Team (2021). R: A language and environment for statistical computing. R Foundation for Statistical Computing. https://www.R-project.org/ ↩
Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77-101. https://doi.org/10.1191/1478088706qp063oa ↩
Ragin, C. C. (1987). The comparative method: Moving beyond qualitative and quantitative strategies. University of California Press. ↩
Bardach, E., & Patashnik, E. M. (2015). A practical guide for policy analysis: The eightfold path to more effective problem solving. CQ Press. ↩
Department of Health, Education, and Welfare. (1979). The Belmont Report: Ethical principles and guidelines for the protection of human subjects of research. https://www.hhs.gov/ohrp/regulations-and-policy/belmont-report/index.html
FAIR. (2020). Ensuring fair and respectful treatment of athletes of all genders. Feminist Alliance for International Rights.
Resnik, D. B. (2015). What is ethics in research & why is it important? National Institute of Environmental Health Sciences. https://www.niehs.nih.gov/research/resources/bioethics/whatis/index.cfm
Sieber, J. E., & Stanley, B. (1988). Ethical and professional dimensions of socially sensitive research. American Psychologist, 43(1), 49-55. https://doi.org/10.1037/0003-066X.43.1.49
WADA. (2021). World Anti-Doping Code. World Anti-Doping Agency. https://www.wada-ama.org/en/what-we-do/the-code
Kanayama, G., Hudson, J. I., & Pope, H. G. (2010). Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: A looming public health concern? Drug and Alcohol Dependence, 108(1-2), 87-94.
Pope, H. G., Phillips, K. A., & Olivardia, R. (2000). The Adonis complex: The secret crisis of male body obsession. New York: Free Press. Sagoe, D., Molde, H., Andreassen, C. S., Torsheim, T., & Pallesen, S. (2014). The global epidemiology of anabolic-androgenic steroid use: A meta-analysis and meta-regression analysis. Annals of Epidemiology, 24(5), 383-398.